{
    "code": 0,
    "data": [
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0d53ef6-1e90-4be1-bd91-9a96c625a62e.pdf",
            "news_date": "2026-02-11 12:49:18"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Recording of the Earnings Conference call for Q3 FY 26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=196440a8-ce1a-48c0-9c43-a17f0416bf7f.pdf",
            "news_date": "2026-02-10 22:34:24"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Corrigendum To Intimation Of Record Date For Dividend Dated February 09 2026.",
            "news_body": "Please find enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20797e12-e440-47f0-8a24-8bb1ea7c5d4f.pdf",
            "news_date": "2026-02-10 13:44:48"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q3 FY 26",
            "news_id": "1ee409e3-0c03-4ab5-877c-8be74f2da5fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c371bec7-ba30-43fc-831f-cf12647c167a.pdf",
            "news_date": "2026-02-10 12:55:35",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q3 FY 26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c371bec7-ba30-43fc-831f-cf12647c167a.pdf",
            "news_date": "2026-02-10 12:55:35"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of 10457 Equity Shares pursuant to Aarti Pharma Perfomance Stock Option Plan 2023 (PSOP 2023)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=997567d2-a3fd-4f83-b602-5cc63e314f69.pdf",
            "news_date": "2026-02-09 20:28:33"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Fixation Of Record Date For Interim Dividend",
            "news_body": "Record Date for Interim Dividend is February 16 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=882fcf66-6394-477c-b345-7ebf7213d9b3.pdf",
            "news_date": "2026-02-09 20:21:05"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Declaration of Interim Dividend at the rate of Rs. 1.5 per equity shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06d4e3aa-ebce-4b0d-941a-faaa653188b9.pdf",
            "news_date": "2026-02-09 20:18:26"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Financial Results for the quarter and nine months ended December 31 2025",
            "news_id": "e54c23b1-a0c6-4aa5-90c8-c908fcc90836",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=672dd8eb-5635-41b0-b0b8-2e277ec67374.pdf",
            "news_date": "2026-02-09 20:10:40",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Financial Results for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=672dd8eb-5635-41b0-b0b8-2e277ec67374.pdf",
            "news_date": "2026-02-09 20:10:40"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 9 2026",
            "news_body": "Outcome of Board meeting held on February 9 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bec7f8f8-d928-497a-aeef-36292248aedd.pdf",
            "news_date": "2026-02-09 20:03:04"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please find attached",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d938376-a170-4083-bfbc-c587c2b7ecdc.pdf",
            "news_date": "2026-02-06 16:14:33"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "This is to inform you that the Earnings Conference Call for Investors and Analysts which would be a Group meet has been scheduled on Tuesday February 10 2026 at 4:00 P.M. (IST) to discuss the Companys Q3-FY26 Financial Results.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43cc04d8-3154-4cdd-9079-0687480caf66.pdf",
            "news_date": "2026-02-02 14:51:23"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for 1. Board Meeting Intimation For Unaudited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2025\r\n2. Declaration Of Interim Dividend If Any On The Equity Share Capital Of The Company For The Fi",
            "news_body": "Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve 1. Unaudited Financial Results of the Company for the quarter and nine-months ended December 31 2025 after these results are reviewed by the Audit Committee of the Board.\r\n2. Declaration of Interim Dividend if any on the equity share capital of the Company for the Financial Year 2025-26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70ce7c1d-30a1-4d0f-b531-2801f592be0b.pdf",
            "news_date": "2026-01-29 14:51:56"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Clarification With Respect To Increase In Volume",
            "news_body": "Please find attached clarifciation with respect to increase in volume",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45302cb7-bac5-4709-8c43-2b975629058f.pdf",
            "news_date": "2026-01-12 14:44:21"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Aarti Pharmalabs Ltd",
            "news_body": "The Exchange has sought clarification from Aarti Pharmalabs Ltd on January 12 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2026-01-12 12:18:09"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb50ce34-d46f-4c8f-ab1d-1093f21f4173.pdf",
            "news_date": "2026-01-06 16:55:58"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d441a5e1-9879-43c7-94d1-d9a03793dfb9.pdf",
            "news_date": "2026-01-01 17:03:29"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3390870-a792-49cb-a7f6-861b29e24247.pdf",
            "news_date": "2025-12-22 11:29:04"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2 FY 26 Earnings Conference Call.",
            "news_id": "9f15fe40-7d51-4f5c-9d14-29bf6fad72e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=085f5cd1-1ce8-443f-8f57-58a02d1d7258.pdf",
            "news_date": "2025-11-17 17:29:06",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2 FY 26 Earnings Conference Call.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=085f5cd1-1ce8-443f-8f57-58a02d1d7258.pdf",
            "news_date": "2025-11-17 17:29:06"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Recording of the Earnings Conference call for Q2 FY 26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67edc55c-8411-4f80-8239-e10432345a92.pdf",
            "news_date": "2025-11-11 18:42:56"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a99aad8-535a-4387-a7b1-35221624d537.pdf",
            "news_date": "2025-11-11 14:44:51"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2 FY 26",
            "news_id": "7c30b0e8-996b-4047-afa1-ed9ca484773f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46d58674-e6a3-408b-8347-9ef5132efe9b.pdf",
            "news_date": "2025-11-11 08:18:15",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2 FY 26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46d58674-e6a3-408b-8347-9ef5132efe9b.pdf",
            "news_date": "2025-11-11 08:18:15"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Half Year Ended September 30 2025",
            "news_body": "Please find enclosed.",
            "news_id": "26b00cd9-d4fe-4ca3-8487-8ddefe3fd682",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=121daa9d-5c82-4fe8-b1ff-6e96e46485c8.pdf",
            "news_date": "2025-11-09 16:27:27",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For Quarter And Half Year Ended September 30 2025",
            "news_body": "Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=121daa9d-5c82-4fe8-b1ff-6e96e46485c8.pdf",
            "news_date": "2025-11-09 16:27:27"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29b01dda-a744-4a67-ab43-63f51f3820e6.pdf",
            "news_date": "2025-11-09 15:25:46"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=281505af-09b9-4c45-bc5c-1d42b44828c1.pdf",
            "news_date": "2025-11-09 15:24:46"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d39774fb-f1bd-4a53-8c11-f2fc809379b7.pdf",
            "news_date": "2025-11-09 14:02:43"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "This is to inform you that the Earnings Conference Call for Investors and Analysts which would be a Group meet has been scheduled on Tuesday November 11 2025 at 4:00 P.M. (IST) to discuss the Companys Q2-FY26 Financial Results.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53b287d8-5843-44e4-ba22-b960611f9db2.pdf",
            "news_date": "2025-11-04 18:21:35"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Standalone And Consolidated Financial Results For The Second Quarter And Half Year Ended September 30 2025",
            "news_body": "Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2025 inter alia to consider and approve Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24ed36ab-8d30-41be-aca4-95c22a77b7b2.pdf",
            "news_date": "2025-10-27 16:36:45"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4253bb31-bc5c-4265-8406-138ad3e6da1f.pdf",
            "news_date": "2025-10-13 19:16:26"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Ex-Parte Ad-Interim Injunction Order Regarding Pharmaceutical Drug Product Containing Ruxolitinib And/Or Ruxolitinib Phosphate API",
            "news_body": "Please find enclosed disclosure under Regulation 30 SEBI LODR 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d81bf599-0273-4ec3-820a-0974c515cd95.pdf",
            "news_date": "2025-10-08 10:56:58"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9468f6f0-b771-444f-9b77-4fd1ea02437a.pdf",
            "news_date": "2025-10-07 18:24:58"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37eb2b24-3297-4a62-ba08-714fa6e1bc6c.pdf",
            "news_date": "2025-09-25 15:36:28"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Safechem Enterprises Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=435DCF33_BB0F_43BD_9D22_88679A527B59_102348.pdf",
            "news_date": "2025-09-24 10:23:52"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed",
            "news_id": "f29185fd-5527-44d3-a98d-b573a03a1111",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfbef63c-c610-46a5-97e5-f2e40eb3bff2.pdf",
            "news_date": "2025-09-23 19:53:41",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfbef63c-c610-46a5-97e5-f2e40eb3bff2.pdf",
            "news_date": "2025-09-23 19:53:41"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66dc8d63-e6d7-41c0-94a1-89207855b4b7.pdf",
            "news_date": "2025-09-23 19:36:23"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Scrutinizers Report and Voting Result of 6th Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cb7126b-7aed-499d-8830-5acec139c8cd.pdf",
            "news_date": "2025-09-23 18:24:47"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings of 6th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fa68ddf-faa9-4494-a409-09c22496d584.pdf",
            "news_date": "2025-09-22 15:43:44"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement for the 100 Days Campaign - \"Saksham Niveshak\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dad432d5-4716-450f-92d4-da4e53cfe6d4.pdf",
            "news_date": "2025-09-18 17:16:16"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c53de91e-3edf-408b-9e81-317153f2eaac.pdf",
            "news_date": "2025-09-18 13:37:05"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find attached Press Release dated September 03 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c278c2d9-9ac3-4178-b5e5-6e9b510c6f39.pdf",
            "news_date": "2025-09-03 14:25:02"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached newspaper publication for completion of dispatch of Annual Report and Notice of 6th Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dff4e003-9f93-4446-b195-0c294496dcf0.pdf",
            "news_date": "2025-08-30 21:46:05"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for FY 24-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69fd87cd-446d-4633-aa91-782acecc209b.pdf",
            "news_date": "2025-08-29 12:16:27"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Please find attached BRSR for FY 24-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a000c6b6-a023-48de-82f0-2d6d61f899bf.pdf",
            "news_date": "2025-08-29 12:02:59"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 6Th Annual General Meeting",
            "news_body": "Please find attached Notice of 6th Annual General Meeting along with Annual Report for FY 2024-25 of Aarti Pharmalabs Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eccde5fa-39bc-464a-9ba0-50a18a9e84ab.pdf",
            "news_date": "2025-08-29 10:34:03"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding 100 Days Campaign - Saksham Niveshak",
            "news_body": "Please see attached for Intimation Regarding 100 days Campaign - \"Saksham Niveshak\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=213e4566-39cf-448c-b90d-ab281d6a6115.pdf",
            "news_date": "2025-08-21 19:41:05"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68a664bb-27ce-43fb-8c65-8cc4ec5d4b7c.pdf",
            "news_date": "2025-08-20 13:52:20"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript for Q1 FY26 Earnings Conference Call",
            "news_id": "9cb29a46-9f4b-4ef0-9f23-234ccaf622ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=913c9018-5c3a-45aa-807f-ee7a59e50b76.pdf",
            "news_date": "2025-08-20 13:41:23",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript for Q1 FY26 Earnings Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=913c9018-5c3a-45aa-807f-ee7a59e50b76.pdf",
            "news_date": "2025-08-20 13:41:23"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Record Date For Final Dividend For FY 2024-25",
            "news_body": "Record Date for Dividend for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a51ebbaf-ecd9-41f1-8ce6-385421ae4247.pdf",
            "news_date": "2025-08-19 15:34:24"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=976131db-b2ff-4639-83d6-58adda96bb2f.pdf",
            "news_date": "2025-08-14 16:00:04"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Recording of the Earnings Conference call for Q1 FY 26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4282bd96-28d4-4402-b9e2-c7658ac1f3cf.pdf",
            "news_date": "2025-08-13 18:34:04"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q1 FY 26",
            "news_id": "cdf0c612-b96a-44b9-84c5-67905e888338",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4a5587f-7ee8-4fb7-8ee5-07d93610c2a8.pdf",
            "news_date": "2025-08-13 12:46:36",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q1 FY 26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4a5587f-7ee8-4fb7-8ee5-07d93610c2a8.pdf",
            "news_date": "2025-08-13 12:46:36"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b36726d-3823-42f2-b659-55878e20a0dd.pdf",
            "news_date": "2025-08-12 20:02:14"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Reappointment of Ms. Rupal Vora Non-Executive Independent Director.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6eae8ba9-a62b-4b93-8255-f817833b100b.pdf",
            "news_date": "2025-08-12 19:27:05"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended June 30 2025",
            "news_body": "Please find enclosed.",
            "news_id": "0d13fab0-57d0-45bf-9d11-6406d8ff43cb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0062c62b-b124-472a-8148-baa7a1f61e66.pdf",
            "news_date": "2025-08-12 19:24:20",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For Quarter Ended June 30 2025",
            "news_body": "Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0062c62b-b124-472a-8148-baa7a1f61e66.pdf",
            "news_date": "2025-08-12 19:24:20"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Secretarial Auditor",
            "news_body": "Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b72ebf3f-ca7c-4005-86dc-7fc8f8fa8a45.pdf",
            "news_date": "2025-08-12 19:16:57"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Unaudited Financial Results With Limited Review Report For The Quarter Ended June 30 2025",
            "news_body": "Please find enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2e00f66-bf21-43a4-963e-8fecff78ebb3.pdf",
            "news_date": "2025-08-12 19:10:52"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "This is to inform you that the Earnings Conference Call for Investors and Analysts which would be a Group meet has been scheduled on Wednesday August 13 2025 at 4:00 P.M. (IST) to discuss the Companys Q1-FY26 Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eaadb125-22be-4648-8982-9d90d1544bad.pdf",
            "news_date": "2025-08-05 17:43:14"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For Unaudited Financial Results For The Quarter Ended June 30 2025.",
            "news_body": "Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve The unaudited financial results (standalone and consolidated) for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e6c1566-4e08-41a2-91b1-342e26777481.pdf",
            "news_date": "2025-08-01 12:13:38"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Please find enclosed credit rating received from CRISIL Ratings Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=685a8f35-82f3-4632-ae0f-990eb0da0ab2.pdf",
            "news_date": "2025-07-17 15:18:56"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0902d1a1-b8eb-4223-96b3-c14d768bf8c1.pdf",
            "news_date": "2025-07-09 12:16:11"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42a5322a-9c84-444b-b737-72228010a598.pdf",
            "news_date": "2025-06-25 16:26:35"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Earnings Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=837f76e9-8157-4e9e-b4e5-604d0ca7542c.pdf",
            "news_date": "2025-06-18 15:55:08"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report for the Financial Year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7835cf66-16b5-400e-9632-9c372b3afc30.pdf",
            "news_date": "2025-05-20 17:46:30"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q4/H2 FY25 Earnings Conference Call",
            "news_id": "bc7925cf-1e95-46e1-81b4-a8a7618b946b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7381a766-ad0c-4780-a1cc-833b7bee3c29.pdf",
            "news_date": "2025-05-16 14:39:09",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q4/H2 FY25 Earnings Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7381a766-ad0c-4780-a1cc-833b7bee3c29.pdf",
            "news_date": "2025-05-16 14:39:09"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Recording of the Earnings Conference call for Q4 FY 25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3c74d9b-88e6-4614-a1d1-c4885ecb501c.pdf",
            "news_date": "2025-05-12 18:52:44"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9674ddd-acd5-48c8-b386-35072288406f.pdf",
            "news_date": "2025-05-12 12:32:51"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q4 FY 25",
            "news_id": "509a54d5-61b6-41c6-95e7-89eaea01c61d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df45d866-44c7-4002-af15-877424037137.pdf",
            "news_date": "2025-05-12 12:27:37",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q4 FY 25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df45d866-44c7-4002-af15-877424037137.pdf",
            "news_date": "2025-05-12 12:27:37"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Grant Of Options Under PSOP Scheme 2023",
            "news_body": "Grant of options under the APL Performance Stock Option Plan 2023 (PSOP 2023)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b046aa3-6396-44c2-9326-1ad4a855e55f.pdf",
            "news_date": "2025-05-10 21:43:55"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Dividend Updates",
            "caption": "Announcement under Regulation 30 (LODR)-Dividend Updates",
            "news_body": "Board Recommends the Final Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97cd22ff-247d-45fa-bebb-8b0f60e42654.pdf",
            "news_date": "2025-05-10 19:25:49"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Financial Year Ended 31.03.2025",
            "news_body": "Outcome of the Board Meeting and Results for the financial year ended 31.03.2025",
            "news_id": "3cf0db59-f410-4a2b-a71e-640a7f155add",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a152e817-846d-4623-ab63-d7cbabafeb05.pdf",
            "news_date": "2025-05-10 19:20:26",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results For The Financial Year Ended 31.03.2025",
            "news_body": "Outcome of the Board Meeting and Results for the financial year ended 31.03.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a152e817-846d-4623-ab63-d7cbabafeb05.pdf",
            "news_date": "2025-05-10 19:20:26"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 10 May 2025",
            "news_body": "The Audited Financial Results and Statements of the Company (Standalone and\r\nConsolidated) for the Quarter and Year ended March 31 2025 based on the\r\nrecommendation of the Audit Committee.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c5833f8-d561-4d5b-ab4b-cd1055ff7071.pdf",
            "news_date": "2025-05-10 19:12:57"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "This is to inform you that the Earnings Conference Call for Investors and Analystswhich would be a Group meet has been scheduled on Monday May 12 2025 at 4:00 P.M. (IST) to discuss the Companys Q4-FY25/FY25 Results.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1837149-d851-4a74-ad3b-d036b586f978.pdf",
            "news_date": "2025-05-05 17:48:30"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release intimation under Regulation 30 of SEBI LODR 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94fbeb50-4a0e-4210-8911-dd733bec9926.pdf",
            "news_date": "2025-04-29 11:18:27"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Audited Financial Results For The Year Ended March 31 2025 And Recommendation Of Dividend If Any For The Financial Year Ended March 31 2025.",
            "news_body": "Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2025 inter alia to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31 2025 and recommendation of dividend if any for the financial year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=505744dd-a19b-4382-b349-de00157bdb87.pdf",
            "news_date": "2025-04-25 10:28:41"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Change In Email And Website Address Of Registrar And Share Transfer Agent (RTA)",
            "news_body": "Intimation of change in email and website of the RTA",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2e42a53-c1fb-4d49-a55b-53ddb29ce450.pdf",
            "news_date": "2025-04-18 14:43:22"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release intimation under Regulation 30 of SEBI LODR",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b2c4bb7-f4d3-4f2c-ab07-c99a0e106799.pdf",
            "news_date": "2025-04-16 15:24:55"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate for the quarter ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa76ffd9-b515-4043-88cc-189a63c47916.pdf",
            "news_date": "2025-04-08 11:17:44"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Joint Venture",
            "caption": "Announcement under Regulation 30 (LODR)-Joint Venture",
            "news_body": "Entering into addendum to the Subscription and Shareholders agreement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f2d6b28-0fed-4e68-b99b-bb9af65e4b5f.pdf",
            "news_date": "2025-04-01 08:10:06"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=518d3617-4ad1-44ff-8dee-fbcf83c86e76.pdf",
            "news_date": "2025-03-20 17:00:39"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of Shares under PSOP 2023",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02ec329e-f168-4992-8c93-74aa7ddb29a5.pdf",
            "news_date": "2025-03-10 17:53:50"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3/9M Earnings Conference call",
            "news_id": "4e52d4bb-1c00-403c-bc98-ee23278e3dbf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=691228af-f2ae-415b-9a46-f5b6137b6a03.pdf",
            "news_date": "2025-02-12 16:39:48",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3/9M Earnings Conference call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=691228af-f2ae-415b-9a46-f5b6137b6a03.pdf",
            "news_date": "2025-02-12 16:39:48"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Recording of the Earnings Conference call for Q3 FY 25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=536b0e5e-be49-455d-a89b-3a4a2ad3f5d7.pdf",
            "news_date": "2025-02-07 18:29:39"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of the Audited Financial Results for Quarter ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8385f4d8-4056-494a-ba2c-cb24aeb56ad8.pdf",
            "news_date": "2025-02-07 11:33:44"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Quarter ended December 31 2024",
            "news_id": "5719b08e-a0ab-49a7-8d57-97926e7d0095",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ded98d2-7458-423b-ba41-f7de69b66199.pdf",
            "news_date": "2025-02-06 16:42:01",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Quarter ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ded98d2-7458-423b-ba41-f7de69b66199.pdf",
            "news_date": "2025-02-06 16:42:01"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Record Date For Interim Dividend",
            "news_body": "Record Date for Interim Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89814406-d63a-400f-a636-db7b68c9129e.pdf",
            "news_date": "2025-02-05 19:36:14"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board to consider Dividend",
            "news_body": "Board approved the Interim Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=063e92d5-0402-4515-8da3-bacaeb30a59e.pdf",
            "news_date": "2025-02-05 19:34:32"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Filing (Financials) for the Quarter ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad211a37-fdbe-41bd-ad8f-1c2b731a0f6c.pdf",
            "news_date": "2025-02-05 19:25:35"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended December 31 2024",
            "news_body": "Financials Results for Quarter ended December 31 2024",
            "news_id": "b2c91e19-9829-4175-a3c3-1b14d83c644e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7575e0ec-593a-4389-b0a9-19feb368edea.pdf",
            "news_date": "2025-02-05 19:16:50",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For Quarter Ended December 31 2024",
            "news_body": "Financials Results for Quarter ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7575e0ec-593a-4389-b0a9-19feb368edea.pdf",
            "news_date": "2025-02-05 19:16:50"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Financial Results For Quarter Ended December 31 2024",
            "news_body": "Financial Results For Quarter Ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74e6db33-beec-4fc3-96ef-c037c0c5f538.pdf",
            "news_date": "2025-02-05 19:11:46"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "This is to inform you that the Earnings Conference Call for Investors and Analysts which would be a Group meet has been scheduled on Friday February 07 2025 at 04:00 p.m. (IST) to discuss the Companys Q3 FY25 Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87aefcea-4dc2-45f0-9ca8-7a9112a4c5ae.pdf",
            "news_date": "2025-01-28 11:50:33"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2024 And 2. Declaration Of Interim Dividend If Any On The Equity Share Capital O",
            "news_body": "Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve 1. Audited Financial Results of the Company for the quarter and nine-months ended December 31 2024 after these results are reviewed by the Audit Committee of the Board.\r\n\r\n2. Declaration of Interim Dividend if any on the equity share capital of the Company for the Financial Year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a26e30c3-8ae0-4b9c-97bb-bc84d09ad00d.pdf",
            "news_date": "2025-01-28 11:19:30"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Re-Opening Of Manufacturing Activities At The CompanyS Vapi Plant",
            "news_body": "Re-opening of Manufacturing activities at the Companys Vapi Plant",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96744beb-7131-4345-b581-78d57406c184.pdf",
            "news_date": "2025-01-18 15:09:52"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate for the Quarter ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b936af2-20f2-487e-a565-65f8c4e2460c.pdf",
            "news_date": "2025-01-10 10:58:08"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Acquisition by entering into a Power Purchase Agreement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c63d2897-ce71-4834-8afe-a8519a297ed9.pdf",
            "news_date": "2025-01-09 17:06:56"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Closure Of Manufacturing Activities At The\nCompanyS Vapi Plant",
            "news_body": "Closure of manufacturing activities at Vapi Plant",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48428449-7c7b-44d1-8f59-187fcf82770a.pdf",
            "news_date": "2025-01-03 13:17:46"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Orchid Family Trust & Others",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ECD40D4_A092_4FA6_B4D4_D49134B2A109_130812.pdf",
            "news_date": "2024-12-30 13:08:15"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Orchid Family Trust & Others",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=B1179935_AA04_4D4D_99BD_86F1DD107155_123118.pdf",
            "news_date": "2024-12-30 12:31:22"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "",
            "descriptor": "",
            "caption": "Disclosure under Regulation 30A of LODR",
            "news_body": "Intimation for signing of Shareholder''s agreement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c78d8914-dfc3-4f62-b30f-4b1abbb55f0f.pdf",
            "news_date": "2024-12-17 11:03:12"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting held on December 13, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39cf71cc-a8e3-43ea-827d-931162cb6b44.pdf",
            "news_date": "2024-12-13 15:32:39"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Company Update",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Appointment of Company Secretary and Compliance officer w.e.f. December 13, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d73360a-40b9-4f66-867d-2809fd42c023.pdf",
            "news_date": "2024-12-13 15:28:00"
        },
        {
            "co_code": 75909,
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3caabb7c-8d41-4269-96dc-1d8d87968976.pdf",
            "news_date": "2024-12-10 15:56:08"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2/H1 FY 25 Earnings conference call",
            "news_id": "99b1e686-b1b6-4e29-9bdf-9288db52f9d2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2da4905-4ad1-46bd-8d29-2b74ca8afda4.pdf",
            "news_date": "2024-11-04 17:08:18",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and half year ended September 30, 2024",
            "news_id": "99ea1675-3464-44c0-9626-f0ba71401ffc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed8a6d03-5e28-4ac8-87d2-29bddedd0ad6.pdf",
            "news_date": "2024-10-28 16:19:52",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1 FY 25 Earnings Conference Call",
            "news_id": "3fdfdb0b-f736-4ea9-abcc-cd7750d01140",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ae85bac-cde9-46c5-8997-87a988f6e0af.pdf",
            "news_date": "2024-08-09 15:07:32",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation made at the 5th Annual General Meeting",
            "news_id": "be7b4d49-fb0e-4fab-b4e8-e18e6c4e6c6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a24dcd5f-351c-4b14-9722-b5d8b340a486.pdf",
            "news_date": "2024-08-07 15:59:23",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q1 FY 25 Investor Presentation",
            "news_id": "9441e56b-0973-4d37-a03d-7e2c8b393b25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abb5aacd-3fd1-478d-b77e-874b53afaccc.pdf",
            "news_date": "2024-08-05 22:58:40",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Financial Results for the Quarter ended June 30, 2024",
            "news_id": "454c18cd-387d-4bbe-b6ed-a778424b5678",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69c96790-269c-414a-ab77-806aeb74fe28.pdf",
            "news_date": "2024-08-05 15:46:59",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q4 FY 24 Earnings Conference Call",
            "news_id": "5c031c55-1c76-42f8-87a8-d4805066a3a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53d2104f-90fd-42a1-947c-3f924a2a6618.pdf",
            "news_date": "2024-05-17 18:21:42",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q4 FY 24 /FY 24 Investor Presentation",
            "news_id": "da5e6f1e-f6d4-44a6-a2da-e0884cbdb6a5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb4b71f5-f003-4840-b149-6f1a759025b6.pdf",
            "news_date": "2024-05-15 10:26:04",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financials For The Year Ended March 31, 2024",
            "news_body": "Audited Financial Results for the quarter and year ended March 31, 2024.",
            "news_id": "1280d4c2-e570-4049-b8b4-99cc46eb312f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7be682ba-c3f2-464f-8eb1-198eb09a09f7.pdf",
            "news_date": "2024-05-13 17:37:49",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "9f333b44-f07f-4b3f-b789-6b9680a89912",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0346392-c27d-4b04-bd71-73e3d122cfe3.pdf",
            "news_date": "2024-05-13 17:27:35",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3 FY24 Earnings conference call",
            "news_id": "91b9fdb1-2173-4cc6-a19b-dbb711a132b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7b4e7b9-3254-425b-befd-c132c7186e6e.pdf",
            "news_date": "2024-02-13 15:42:52",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 FY24 Investor Presentation",
            "news_id": "889c59ae-6194-494e-ba6e-8bfc432a9c6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d586692-fd79-4de0-b188-e4bb9a3a3ab2.pdf",
            "news_date": "2024-02-08 15:46:53",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Audited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2023",
            "news_id": "6cb15cd2-5bf3-46c8-ad95-5c3df7c806aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9152347-fd1f-400f-9257-c4b1d28fbb39.pdf",
            "news_date": "2024-02-07 16:42:18",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call for Q2 FY24 Financial Results held on November 9, 2023",
            "news_id": "fb5202a0-4f09-4093-8962-515748d161a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c72a03d1-5884-456a-ab15-09a439124b33.pdf",
            "news_date": "2023-11-13 22:41:06",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call of Financial Results for Q2/ H1 FY24",
            "news_id": "51299c1e-58c8-44df-8208-e042ba1bebff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72036700-355e-42f7-bac5-5b0f29b93386.pdf",
            "news_date": "2023-11-09 21:39:23",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 FY24 Results Presentation",
            "news_id": "fd0f2e9d-3a2f-4563-bd32-a3bf26f986ae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a85ec1f8-fe5d-4878-b428-1097714d7a3a.pdf",
            "news_date": "2023-11-08 20:29:30",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Financial Results for the quarter and half year ended September 30, 2023",
            "news_id": "9190020a-cbfa-4486-9c2f-934658184012",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39f61e20-26a8-4287-ac71-90d8abb7dc2a.pdf",
            "news_date": "2023-11-07 18:39:14",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to Shareholders of the Company at the 4th Annual General Meeting",
            "news_id": "d037fb5c-eee6-4e4c-bbdc-18cccc450890",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de454294-e7e3-4cec-86bf-36b4d763e32f.pdf",
            "news_date": "2023-09-14 16:52:36",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call held on August 10, 2023 on the Q1 FY24 Results",
            "news_id": "0818a494-316f-46b5-9265-ad78cabefb88",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=952fd5aa-2c88-42e5-b07f-bd0624195579.pdf",
            "news_date": "2023-08-16 11:16:51",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/ Analyst Quarterly Earnings Call on the Financial Results of the Company for the Quarter ended June 30, 2023.",
            "news_id": "1a0c970d-d97a-4627-bf7c-15473f355f39",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cfa6d16-1c74-4758-9151-23483a941121.pdf",
            "news_date": "2023-08-10 22:19:09",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q1 FY24 Results Presentation of the Company",
            "news_id": "789079ed-b69f-4964-b3ab-78a7d09a9553",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f34ff8e9-a28c-4eca-9e94-f657ad90076e.pdf",
            "news_date": "2023-08-10 15:28:38",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2023.",
            "news_id": "0877b4ac-68b8-462f-9554-72500b33a48a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=741afc91-e619-4d30-993c-cd8b5849852e.pdf",
            "news_date": "2023-08-05 15:59:06",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Outcome of the Board Meeting held on Saturday, August 05, 2023.",
            "news_id": "c3ae1f75-e123-4b01-b4b6-45d1e7bd243e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a6ba501-3be9-4bb3-922d-459ee14d288d.pdf",
            "news_date": "2023-08-05 15:52:42",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Analyst Presentation of the Company.",
            "news_id": "cd483766-0a6a-44f3-9c4a-6d8af9f968a7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92dd9da5-2e7d-4944-8a25-7bdb948e40cb.pdf",
            "news_date": "2023-06-26 16:03:14",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results_Financial Results For March 31,2023",
            "news_body": "Audited Financial Results (Standalone and Consolidated) for Quarter and Year Ended March 31, 2023.",
            "news_id": "1256e66e-4edb-4d71-b67c-0749605181bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a6adeb3-b136-4687-aae2-2773e84da541.pdf",
            "news_date": "2023-05-12 19:09:14",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Statements For The Nine Months Ended December 31, 2022",
            "news_body": "Financial Statements for the nine months ended December 31, 2022<BR>",
            "news_id": "b7ad89d8-57b7-4da4-b95a-00bfa673470d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bddf2178-3021-45a6-b0e9-9e2b393f23fc.pdf",
            "news_date": "2023-02-14 17:22:54",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}